168 related articles for article (PubMed ID: 16856837)
1. The molecular machinery for cAMP-dependent immunomodulation in T-cells.
Taskén K; Stokka AJ
Biochem Soc Trans; 2006 Aug; 34(Pt 4):476-9. PubMed ID: 16856837
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-mediated immune regulation--overview of mechanisms of action in T cells.
Mosenden R; Taskén K
Cell Signal; 2011 Jun; 23(6):1009-16. PubMed ID: 21130867
[TBL] [Abstract][Full Text] [Related]
3. Role of cAMP phosphodiesterase 4 in regulation of T-cell function.
Bjørgo E; Taskén K
Crit Rev Immunol; 2006; 26(5):443-51. PubMed ID: 17341187
[TBL] [Abstract][Full Text] [Related]
4. Spatiotemporal control of cyclic AMP immunomodulation through the PKA-Csk inhibitory pathway is achieved by anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells.
Cornez I; Taskén K
FEBS Lett; 2010 Jun; 584(12):2681-8. PubMed ID: 20420835
[TBL] [Abstract][Full Text] [Related]
5. TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling.
Abrahamsen H; Baillie G; Ngai J; Vang T; Nika K; Ruppelt A; Mustelin T; Zaccolo M; Houslay M; Taskén K
J Immunol; 2004 Oct; 173(8):4847-58. PubMed ID: 15470025
[TBL] [Abstract][Full Text] [Related]
6. Novel mechanism of signaling by CD28.
Bjørgo E; Taskén K
Immunol Lett; 2010 Mar; 129(1):1-6. PubMed ID: 20123110
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts.
Tasken K; Ruppelt A
Front Biosci; 2006 Sep; 11():2929-39. PubMed ID: 16720365
[TBL] [Abstract][Full Text] [Related]
8. Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex.
Bjørgo E; Solheim SA; Abrahamsen H; Baillie GS; Brown KM; Berge T; Okkenhaug K; Houslay MD; Taskén K
Mol Cell Biol; 2010 Apr; 30(7):1660-72. PubMed ID: 20086095
[TBL] [Abstract][Full Text] [Related]
9. The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP.
Stokka AJ; Mosenden R; Ruppelt A; Lygren B; Taskén K
Biochem J; 2009 Dec; 425(2):381-8. PubMed ID: 19857202
[TBL] [Abstract][Full Text] [Related]
10. Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligation.
Baroja ML; Cieslinski LB; Torphy TJ; Wange RL; Madrenas J
J Immunol; 1999 Feb; 162(4):2016-23. PubMed ID: 9973473
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterases as targets for modulating T-cell responses.
Bjørgo E; Moltu K; Taskén K
Handb Exp Pharmacol; 2011; (204):345-63. PubMed ID: 21695648
[TBL] [Abstract][Full Text] [Related]
12. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
[TBL] [Abstract][Full Text] [Related]
13. Global analysis of dynamic changes in lipid raft proteins during T-cell activation.
Kobayashi M; Katagiri T; Kosako H; Iida N; Hattori S
Electrophoresis; 2007 Jun; 28(12):2035-43. PubMed ID: 17486660
[TBL] [Abstract][Full Text] [Related]
14. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.
Houslay MD; Adams DR
Biochem J; 2003 Feb; 370(Pt 1):1-18. PubMed ID: 12444918
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin.
Ruppelt A; Mosenden R; Grönholm M; Aandahl EM; Tobin D; Carlson CR; Abrahamsen H; Herberg FW; Carpén O; Taskén K
J Immunol; 2007 Oct; 179(8):5159-68. PubMed ID: 17911601
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of lipid rafts in human activated T cells.
Tani-ichi S; Maruyama K; Kondo N; Nagafuku M; Kabayama K; Inokuchi J; Shimada Y; Ohno-Iwashita Y; Yagita H; Kawano S; Kosugi A
Int Immunol; 2005 Jun; 17(6):749-58. PubMed ID: 15967787
[TBL] [Abstract][Full Text] [Related]
17. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
[TBL] [Abstract][Full Text] [Related]
18. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
[TBL] [Abstract][Full Text] [Related]
19. The inner side of T cell lipid rafts.
Gri G; Molon B; Manes S; Pozzan T; Viola A
Immunol Lett; 2004 Jul; 94(3):247-52. PubMed ID: 15275973
[TBL] [Abstract][Full Text] [Related]
20. Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes.
Baillie GS; Houslay MD
Curr Opin Cell Biol; 2005 Apr; 17(2):129-34. PubMed ID: 15780588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
